SCHEMBL7344853

SCHEMBL7344853

COC(=O)n1nnc2c(CBr)cccc21

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
F12 P00748 4/20 0.34
GAA P10253 4/20 0.34
MGAM O43451 3/20 0.34
AMY1A P0DUB6 3/20 0.34
SI P14410 3/20 0.34
MGAM2 Q2M2H8 3/20 0.34
GRM2 Q14416 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MIF P14174 1/20 0.34
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ASAH1 Q13510 1/20 0.32
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32
FGFR1 P11362 1/20 0.32
FGFR4 P22455 1/20 0.32
F2 P00734 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9994966 0.85 FAAH (0.40) GRM2ALDH1A1L3MBTL1
SCHEMBL7350749 0.76 ASAH1 (0.38) MEN1KMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL9982902 0.73 L3MBTL1 (0.41) ALDH1A1L3MBTL1
SCHEMBL7346527 0.73 L3MBTL1 (0.39) MEN1KMT2AALDH1A1L3MBTL1MTNR1A
SCHEMBL459733 0.71 GAA (0.60) F12GAAMGAMAMY1ASI
SCHEMBL476712 0.70 GRM2 (0.54) GRM2
SCHEMBL9736525 0.70 MEN1 (0.43) GAAMGAMAMY1ASIMGAM2
SCHEMBL7352544 0.69 SYK (0.35) MEN1KMT2AASAH1MTNR1AMTNR1B
SCHEMBL3865262 0.66 SMN1; SMN2 (0.39) ALDH1A1SMN1; SMN2ASAH1
SCHEMBL1162095 0.65 L3MBTL1 (0.41) ALDH1A1L3MBTL1ASAH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed